The following substances are placed on the 2018 Monitoring Program:
In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol and synephrine.
In-Competition only: Codeine, hydrocodone, and tramadol.
In-Competition (by routes of administration other than oral, intravenous, intramuscular or rectal) and Out-of-Competition (all routes of administration).
4. 2-ethylsulfanyl-1Hbenzimidazole (bemitil):
In- and Out-of-Competition.
In- and Out-of-Competition: any combination of beta-2-agonists.
*The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.”